共 57 条
[1]
Glare P.A., Et al., Pain in cancer survivors, J Clin Oncol Off J Am Soc Clin Oncol, 32, 16, pp. 1739-1747, (2014)
[2]
Snijders R.A.H., Brom L., Theunissen M., van den Beuken-van Everdingen M.H.J., Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis, Cancers, 15, 3, (2023)
[3]
van den Beuken-van Everdingen M., Chronic pain in cancer survivors: a growing issue, J Pain Palliat Care Pharmacother, 26, 4, pp. 385-387, (2012)
[4]
Moye J., June A., Martin L.A., Gosian J., Herman L.I., Naik A.D., Pain is prevalent and persisting in cancer survivors: differential factors across age groups, J Geriatr Oncol, 5, 2, pp. 190-196, (2014)
[5]
Tevaarwerk A., Et al., Survivorship, version 1.2021: featured updates to the NCCN guidelines, J Natl Compr Canc Netw, 19, 6, pp. 676-685, (2021)
[6]
Bennett M.I., Et al., The IASP classification of chronic pain for ICD-11: chronic cancer-related pain, Pain, 160, 1, pp. 38-44, (2019)
[7]
Roberto A., Et al., Prevalence of neuropathic pain in cancer patients: pooled estimates from a systematic review of published literature and results from a survey conducted in 50 Italian palliative care centers, J Pain Symptom Manage, 51, 6, pp. 1091-1102.e4, (2016)
[8]
Raja S.N., Et al., The revised international association for the study of pain definition of pain: concepts, challenges, and compromises, Pain, 161, 9, pp. 1976-1982, (2020)
[9]
Kerckhove N., Collin A., Conde S., Chaleteix C., Pezet D., Balayssac D., Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review, Front Pharmacol, 8, (2017)
[10]
Seretny M., Et al., Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis, Pain, 155, 12, (2014)